Fast, efficient and reproducible digestion is critical for LC-MS/MS quantitative bioanalysis of therapeutic proteins. Traditional digestion methods require a pretreatment, such as sequential denaturation, reduction and alkylation, which are very time-consuming. Pellet digestion, which does not require the serial pretreatments of denaturation, reduction and alkylation, was evaluated using a test monoclonal antibody (mAb) with 16 disulfide bonds, and compared with traditional digestion methods. For the test mAb, pellet digestion provided much better digestion efficiency compared with direct digestion, and provided similar or better digestion efficiency compared with digestion-with-pretreatment. In particular, for two peptides with very low digestion efficiency under direct digestion, pellet digestion improved the digestion yield by approximately 30-fold, which was similar to or better than what digestion-with-pretreatment offered. This method was then successfully applied to an LC-MS/MS assay of the test mAb in monkey serum. Pellet digestion will be a very useful technique for high-throughput and reliable LC-MS/MS bioanalysis of mAbs and other large proteins, including ones with multiple disulfide bonds.
Therapeutic oligonucleotides, such as antisense oligonucleotide (ASO) and small interfering RNA (siRNA), are a new class of therapeutics rapidly growing in drug discovery and development. A sensitive and reliable method to quantify oligonucleotides in biological samples is critical to study their pharmacokinetic and pharmacodynamic properties. Hybridization LC-MS/MS was recently established as a highly sensitive and specific methodology for the quantification of single-stranded oligonucleotides, e.g., ASOs, in various biological matrices. However, there is no report of this methodology for the bioanalysis of double-stranded oligonucleotides (e.g., siRNA). In this work, we investigated hybridization LC-MS/MS methodology for the quantification of double-stranded oligonucleotides in biological samples using an siRNA compound, siRNA-01, as the test compound. The commonly used DNA capture probe and a new peptide nucleic acid (PNA) probe were compared for the hybridization extraction of siRNA-01 under different conditions. The PNA probe achieved better extraction recovery than the DNA probe, especially for high concentration samples, which may be due to its stronger hybridization affinity. The optimized hybridization method using the PNA probe was successfully qualified for the quantitation of siRNA-01 in monkey plasma, cerebrospinal fluid (CSF), and tissue homogenates over the range of 2.00–1000 ng/mL. This work is the first report of the hybridization LC-MS/MS methodology for the quantification of double-stranded oligonucleotides. The developed methodology will be applied to pharmacokinetic and toxicokinetic studies of siRNA-01. This novel methodology can also be used for the quantitative bioanalysis of other double-stranded oligonucleotides.